Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Leuvectin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Leuvectin (Vical Inc., San Diego, CA) is a gene transfer product in which a plasmid encoding the human interleukin‐2 (IL‐2) gene… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Twenty-four patients with locally advanced prostate cancer (CaP) were enrolled in a phase I clinical trial using gene-based… Expand
Is this relevant?
Review
2001
Review
2001
  • A. Kaushik
  • Current opinion in investigational drugs
  • 2001
  • Corpus ID: 30058465
Vical's Leuvectin, a plasmid DNA expression vector encoding interleukin-2 (IL-2) complexed with a lipid delivery vehicle (DMRIE… Expand
Is this relevant?
2000
2000
Abstract Metastatic renal-cell carcinoma (RCC) is not responsive to conventional cytotoxic chemotherapy, but a subset of patients… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
PURPOSE We have completed a phase I study, followed by three phase I/II studies, in patients with metastatic melanoma, renal cell… Expand
Is this relevant?
Review
1999
Review
1999
Leuvectin is a plasmid DNA/lipid complex comprised of a plasmid DNA expression vector (VCL-1102, 30) encoding human interleukin… Expand
Is this relevant?